跳到正文
原文
Biotechnology Innovation Organization· @IAmBiotech · X·· 3 小时前AI 评分8
AI 导读

BIO发布"Patient Pioneers"患者先锋故事系列,聚焦急性淋巴细胞白血病、镰状细胞病和多发性硬化症患者参与前沿医学试验的经历。其中Marci Pedrazzi McCue是美国MS试验中首位接受CAR-T细胞疗法的患者,她表示当一心想要阻止疾病时,不怕做"1号患者"。

正文

Every breakthrough begins with patients willing to go first - determined to turn their own fight into hope for others. In BIO's new Patient Pioneers story, patients and families who have faced acute lymphoblastic leukemia, sickle cell disease, and multiple sclerosis reflect on what it means to be among the first to advance a new frontier in medicine - and to move the #FightOfOurLives forward. Their experiences differ, but they share one belief: progress is only possible when patients and scientists take big steps together.

Among them is Marci Pedrazzi McCue, the first person in a U.S. trial to receive CAR-T cell therapy for MS. As she puts it: "I think that when you're in a mindset of trying anything that's available to stop your disease, you're not afraid to be patient number one."

Their courage moves the fight forward - for every patient still waiting.

Watch their stories: https://fightofourlives.com/stories/patient-pioneers-stories/

来源:Biotechnology Innovation Organization · x.com